These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12486127)

  • 1. Manipulation of EphB2 regulatory motifs and SH2 binding sites switches MAPK signaling and biological activity.
    Tong J; Elowe S; Nash P; Pawson T
    J Biol Chem; 2003 Feb; 278(8):6111-9. PubMed ID: 12486127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of the Ras-mitogen-activated protein kinase pathway by the EphB2 receptor tyrosine kinase is required for ephrin-induced neurite retraction.
    Elowe S; Holland SJ; Kulkarni S; Pawson T
    Mol Cell Biol; 2001 Nov; 21(21):7429-41. PubMed ID: 11585923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Juxtamembrane tyrosine residues couple the Eph family receptor EphB2/Nuk to specific SH2 domain proteins in neuronal cells.
    Holland SJ; Gale NW; Gish GD; Roth RA; Songyang Z; Cantley LC; Henkemeyer M; Yancopoulos GD; Pawson T
    EMBO J; 1997 Jul; 16(13):3877-88. PubMed ID: 9233798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Shb scaffold binds the Nck adaptor protein, p120 RasGAP, and Chimaerins and thereby facilitates heterotypic cell segregation by the receptor EphB2.
    Wagner MJ; Hsiung MS; Gish GD; Bagshaw RD; Doodnauth SA; Soliman MA; Jørgensen C; Tucholska M; Rottapel R
    J Biol Chem; 2020 Mar; 295(12):3932-3944. PubMed ID: 32060095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replacing two conserved tyrosines of the EphB2 receptor with glutamic acid prevents binding of SH2 domains without abrogating kinase activity and biological responses.
    Zisch AH; Pazzagli C; Freeman AL; Schneller M; Hadman M; Smith JW; Ruoslahti E; Pasquale EB
    Oncogene; 2000 Jan; 19(2):177-87. PubMed ID: 10644995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple signaling interactions of Abl and Arg kinases with the EphB2 receptor.
    Yu HH; Zisch AH; Dodelet VC; Pasquale EB
    Oncogene; 2001 Jul; 20(30):3995-4006. PubMed ID: 11494128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complex formation between EphB2 and Src requires phosphorylation of tyrosine 611 in the EphB2 juxtamembrane region.
    Zisch AH; Kalo MS; Chong LD; Pasquale EB
    Oncogene; 1998 May; 16(20):2657-70. PubMed ID: 9632142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling.
    Himanen JP; Chumley MJ; Lackmann M; Li C; Barton WA; Jeffrey PD; Vearing C; Geleick D; Feldheim DA; Boyd AW; Henkemeyer M; Nikolov DB
    Nat Neurosci; 2004 May; 7(5):501-9. PubMed ID: 15107857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple in vivo tyrosine phosphorylation sites in EphB receptors.
    Kalo MS; Pasquale EB
    Biochemistry; 1999 Oct; 38(43):14396-408. PubMed ID: 10572014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of EphB2 activation and cell repulsion by feedback control of the MAPK pathway.
    Poliakov A; Cotrina ML; Pasini A; Wilkinson DG
    J Cell Biol; 2008 Dec; 183(5):933-47. PubMed ID: 19047466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The protein tyrosine phosphatase, Shp2, is required for the complete activation of the RAS/MAPK pathway by brain-derived neurotrophic factor.
    Easton JB; Royer AR; Middlemas DS
    J Neurochem; 2006 May; 97(3):834-45. PubMed ID: 16573649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dok-3 sequesters Grb2 and inhibits the Ras-Erk pathway downstream of protein-tyrosine kinases.
    Honma M; Higuchi O; Shirakata M; Yasuda T; Shibuya H; Iemura S; Natsume T; Yamanashi Y
    Genes Cells; 2006 Feb; 11(2):143-51. PubMed ID: 16436051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis for autoinhibition of the Ephb2 receptor tyrosine kinase by the unphosphorylated juxtamembrane region.
    Wybenga-Groot LE; Baskin B; Ong SH; Tong J; Pawson T; Sicheri F
    Cell; 2001 Sep; 106(6):745-57. PubMed ID: 11572780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo tyrosine phosphorylation sites of activated ephrin-B1 and ephB2 from neural tissue.
    Kalo MS; Yu HH; Pasquale EB
    J Biol Chem; 2001 Oct; 276(42):38940-8. PubMed ID: 11466320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosine phosphorylation of Grb2 by Bcr/Abl and epidermal growth factor receptor: a novel regulatory mechanism for tyrosine kinase signaling.
    Li S; Couvillon AD; Brasher BB; Van Etten RA
    EMBO J; 2001 Dec; 20(23):6793-804. PubMed ID: 11726515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recruitment of Dok-R to the EGF receptor through its PTB domain is required for attenuation of Erk MAP kinase activation.
    Jones N; Dumont DJ
    Curr Biol; 1999 Sep; 9(18):1057-60. PubMed ID: 10508618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EphB ligand, ephrinB2, suppresses the VEGF- and angiopoietin 1-induced Ras/mitogen-activated protein kinase pathway in venous endothelial cells.
    Kim I; Ryu YS; Kwak HJ; Ahn SY; Oh JL; Yancopoulos GD; Gale NW; Koh GY
    FASEB J; 2002 Jul; 16(9):1126-8. PubMed ID: 12039842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel role for Gab1 and SHP2 in epidermal growth factor-induced Ras activation.
    Montagner A; Yart A; Dance M; Perret B; Salles JP; Raynal P
    J Biol Chem; 2005 Feb; 280(7):5350-60. PubMed ID: 15574420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PDZ-domain-mediated interaction of the Eph-related receptor tyrosine kinase EphB3 and the ras-binding protein AF6 depends on the kinase activity of the receptor.
    Hock B; Böhme B; Karn T; Yamamoto T; Kaibuchi K; Holtrich U; Holland S; Pawson T; Rübsamen-Waigmann H; Strebhardt K
    Proc Natl Acad Sci U S A; 1998 Aug; 95(17):9779-84. PubMed ID: 9707552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Ephb2 Receptor Uses Homotypic, Head-to-Tail Interactions within Its Ectodomain as an Autoinhibitory Control Mechanism.
    Xu Y; Robev D; Saha N; Wang B; Dalva MB; Xu K; Himanen JP; Nikolov DB
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.